nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—ANXA1—esophageal cancer	0.575	0.897	CbGaD
Hydrocortisone—ABCB1—esophageal cancer	0.0657	0.103	CbGaD
Hydrocortisone—ABCG2—Carboplatin—esophageal cancer	0.0454	0.273	CbGbCtD
Hydrocortisone—ABCG2—Cisplatin—esophageal cancer	0.0388	0.234	CbGbCtD
Hydrocortisone—SLCO1A2—Methotrexate—esophageal cancer	0.0336	0.202	CbGbCtD
Hydrocortisone—ABCG2—Methotrexate—esophageal cancer	0.0252	0.152	CbGbCtD
Hydrocortisone—ABCB1—Cisplatin—esophageal cancer	0.014	0.0843	CbGbCtD
Hydrocortisone—ABCB1—Methotrexate—esophageal cancer	0.00908	0.0547	CbGbCtD
Hydrocortisone—Skin depigmentation—Methotrexate—esophageal cancer	0.00335	0.0398	CcSEcCtD
Hydrocortisone—Mass—Capecitabine—esophageal cancer	0.00258	0.0307	CcSEcCtD
Hydrocortisone—ANXA1—exocrine gland—esophageal cancer	0.00254	0.143	CbGeAlD
Hydrocortisone—Aseptic necrosis—Methotrexate—esophageal cancer	0.00242	0.0288	CcSEcCtD
Hydrocortisone—Paraplegia—Methotrexate—esophageal cancer	0.00206	0.0245	CcSEcCtD
Hydrocortisone—Oesophageal candidiasis—Capecitabine—esophageal cancer	0.00205	0.0244	CcSEcCtD
Hydrocortisone—Personality change—Capecitabine—esophageal cancer	0.00195	0.0233	CcSEcCtD
Hydrocortisone—Diplegia—Methotrexate—esophageal cancer	0.00192	0.0229	CcSEcCtD
Hydrocortisone—Glucose tolerance impaired—Cisplatin—esophageal cancer	0.00189	0.0225	CcSEcCtD
Hydrocortisone—Monoplegia—Methotrexate—esophageal cancer	0.0018	0.0215	CcSEcCtD
Hydrocortisone—ANXA1—neck—esophageal cancer	0.00163	0.0913	CbGeAlD
Hydrocortisone—Papilloedema—Cisplatin—esophageal cancer	0.0016	0.019	CcSEcCtD
Hydrocortisone—Arachnoiditis—Methotrexate—esophageal cancer	0.00153	0.0182	CcSEcCtD
Hydrocortisone—Herpes virus infection—Capecitabine—esophageal cancer	0.00135	0.0161	CcSEcCtD
Hydrocortisone—Telangiectasia—Methotrexate—esophageal cancer	0.00118	0.0141	CcSEcCtD
Hydrocortisone—ANXA1—epithelium—esophageal cancer	0.00111	0.0622	CbGeAlD
Hydrocortisone—ANXA1—bronchus—esophageal cancer	0.00109	0.0612	CbGeAlD
Hydrocortisone—SHBG—neck—esophageal cancer	0.00109	0.061	CbGeAlD
Hydrocortisone—Cognitive impairment—Methotrexate—esophageal cancer	0.00107	0.0127	CcSEcCtD
Hydrocortisone—ANXA1—smooth muscle tissue—esophageal cancer	0.00107	0.0599	CbGeAlD
Hydrocortisone—Oesophageal ulcer—Capecitabine—esophageal cancer	0.00103	0.0122	CcSEcCtD
Hydrocortisone—ANXA1—trachea—esophageal cancer	0.000979	0.055	CbGeAlD
Hydrocortisone—Blindness—Cisplatin—esophageal cancer	0.000918	0.0109	CcSEcCtD
Hydrocortisone—ANXA1—digestive system—esophageal cancer	0.000842	0.0473	CbGeAlD
Hydrocortisone—Diabetic—Methotrexate—esophageal cancer	0.000835	0.00994	CcSEcCtD
Hydrocortisone—Optic neuritis—Cisplatin—esophageal cancer	0.000826	0.00983	CcSEcCtD
Hydrocortisone—Prurigo—Capecitabine—esophageal cancer	0.000811	0.00965	CcSEcCtD
Hydrocortisone—Joint swelling—Capecitabine—esophageal cancer	0.000764	0.00909	CcSEcCtD
Hydrocortisone—Osteonecrosis—Methotrexate—esophageal cancer	0.000749	0.00891	CcSEcCtD
Hydrocortisone—CYP11B2—lymph node—esophageal cancer	0.000706	0.0396	CbGeAlD
Hydrocortisone—ANXA1—lung—esophageal cancer	0.000703	0.0395	CbGeAlD
Hydrocortisone—Opportunistic infection—Methotrexate—esophageal cancer	0.000692	0.00824	CcSEcCtD
Hydrocortisone—Leukoderma—Methotrexate—esophageal cancer	0.000656	0.00781	CcSEcCtD
Hydrocortisone—Necrosis—Cisplatin—esophageal cancer	0.000647	0.0077	CcSEcCtD
Hydrocortisone—Cognitive disorder—Methotrexate—esophageal cancer	0.000645	0.00767	CcSEcCtD
Hydrocortisone—Impaired healing—Methotrexate—esophageal cancer	0.000645	0.00767	CcSEcCtD
Hydrocortisone—Gastric ulcer—Capecitabine—esophageal cancer	0.000645	0.00767	CcSEcCtD
Hydrocortisone—Hirsutism—Capecitabine—esophageal cancer	0.000645	0.00767	CcSEcCtD
Hydrocortisone—Abscess—Cisplatin—esophageal cancer	0.000642	0.00764	CcSEcCtD
Hydrocortisone—Skin hyperpigmentation—Capecitabine—esophageal cancer	0.00063	0.00749	CcSEcCtD
Hydrocortisone—Infection—Carboplatin—esophageal cancer	0.000614	0.00731	CcSEcCtD
Hydrocortisone—Embolism—Capecitabine—esophageal cancer	0.000584	0.00694	CcSEcCtD
Hydrocortisone—NR3C1—neck—esophageal cancer	0.000565	0.0317	CbGeAlD
Hydrocortisone—Hepatomegaly—Capecitabine—esophageal cancer	0.000529	0.0063	CcSEcCtD
Hydrocortisone—Pain—Carboplatin—esophageal cancer	0.000529	0.00629	CcSEcCtD
Hydrocortisone—Hiccups—Cisplatin—esophageal cancer	0.000508	0.00605	CcSEcCtD
Hydrocortisone—Osteoporosis—Methotrexate—esophageal cancer	0.000497	0.00592	CcSEcCtD
Hydrocortisone—Body temperature increased—Carboplatin—esophageal cancer	0.000489	0.00581	CcSEcCtD
Hydrocortisone—Skin exfoliation—Cisplatin—esophageal cancer	0.000485	0.00577	CcSEcCtD
Hydrocortisone—Fungal infection—Capecitabine—esophageal cancer	0.000485	0.00577	CcSEcCtD
Hydrocortisone—Fluid retention—Cisplatin—esophageal cancer	0.000482	0.00574	CcSEcCtD
Hydrocortisone—ANXA1—lymph node—esophageal cancer	0.000481	0.027	CbGeAlD
Hydrocortisone—Multiple fractures—Methotrexate—esophageal cancer	0.00048	0.00571	CcSEcCtD
Hydrocortisone—Fracture—Methotrexate—esophageal cancer	0.00048	0.00571	CcSEcCtD
Hydrocortisone—Neuropathy—Cisplatin—esophageal cancer	0.000477	0.00568	CcSEcCtD
Hydrocortisone—Skin hyperpigmentation—Methotrexate—esophageal cancer	0.000469	0.00558	CcSEcCtD
Hydrocortisone—SLCO1A2—digestive system—esophageal cancer	0.000468	0.0262	CbGeAlD
Hydrocortisone—Tingling sensation—Capecitabine—esophageal cancer	0.000466	0.00555	CcSEcCtD
Hydrocortisone—Petechiae—Capecitabine—esophageal cancer	0.000455	0.00542	CcSEcCtD
Hydrocortisone—Eruption—Methotrexate—esophageal cancer	0.000453	0.00539	CcSEcCtD
Hydrocortisone—Folliculitis—Methotrexate—esophageal cancer	0.000444	0.00528	CcSEcCtD
Hydrocortisone—Embolism—Methotrexate—esophageal cancer	0.000434	0.00517	CcSEcCtD
Hydrocortisone—Contusion—Capecitabine—esophageal cancer	0.000429	0.00511	CcSEcCtD
Hydrocortisone—Skin discolouration—Capecitabine—esophageal cancer	0.000415	0.00494	CcSEcCtD
Hydrocortisone—Rectal haemorrhage—Capecitabine—esophageal cancer	0.000415	0.00494	CcSEcCtD
Hydrocortisone—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000407	0.00484	CcSEcCtD
Hydrocortisone—Cataract—Capecitabine—esophageal cancer	0.000394	0.00468	CcSEcCtD
Hydrocortisone—SLCO1A2—lung—esophageal cancer	0.00039	0.0219	CbGeAlD
Hydrocortisone—Inflammation—Capecitabine—esophageal cancer	0.000386	0.0046	CcSEcCtD
Hydrocortisone—NR3C1—epithelium—esophageal cancer	0.000385	0.0216	CbGeAlD
Hydrocortisone—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000381	0.00454	CcSEcCtD
Hydrocortisone—NR3C1—bronchus—esophageal cancer	0.000379	0.0213	CbGeAlD
Hydrocortisone—Hiccups—Capecitabine—esophageal cancer	0.000375	0.00446	CcSEcCtD
Hydrocortisone—NR3C1—smooth muscle tissue—esophageal cancer	0.000371	0.0208	CbGeAlD
Hydrocortisone—Fungal infection—Methotrexate—esophageal cancer	0.000361	0.0043	CcSEcCtD
Hydrocortisone—Skin exfoliation—Capecitabine—esophageal cancer	0.000358	0.00426	CcSEcCtD
Hydrocortisone—Fluid retention—Capecitabine—esophageal cancer	0.000356	0.00423	CcSEcCtD
Hydrocortisone—Necrosis—Methotrexate—esophageal cancer	0.000355	0.00423	CcSEcCtD
Hydrocortisone—Abscess—Methotrexate—esophageal cancer	0.000352	0.00419	CcSEcCtD
Hydrocortisone—Irritability—Cisplatin—esophageal cancer	0.000352	0.00419	CcSEcCtD
Hydrocortisone—Neuropathy—Capecitabine—esophageal cancer	0.000352	0.00419	CcSEcCtD
Hydrocortisone—Dry eye—Capecitabine—esophageal cancer	0.000346	0.00412	CcSEcCtD
Hydrocortisone—Oesophagitis—Capecitabine—esophageal cancer	0.000342	0.00407	CcSEcCtD
Hydrocortisone—NR3C1—trachea—esophageal cancer	0.00034	0.0191	CbGeAlD
Hydrocortisone—Petechiae—Methotrexate—esophageal cancer	0.000339	0.00403	CcSEcCtD
Hydrocortisone—Ecchymosis—Capecitabine—esophageal cancer	0.000339	0.00403	CcSEcCtD
Hydrocortisone—Hypokalaemia—Cisplatin—esophageal cancer	0.000336	0.00399	CcSEcCtD
Hydrocortisone—Dexamethasone—ANXA1—esophageal cancer	0.000333	0.0922	CrCbGaD
Hydrocortisone—Thrombophlebitis—Capecitabine—esophageal cancer	0.000314	0.00374	CcSEcCtD
Hydrocortisone—Diabetes mellitus—Capecitabine—esophageal cancer	0.000313	0.00372	CcSEcCtD
Hydrocortisone—Pancreatitis—Cisplatin—esophageal cancer	0.000313	0.00372	CcSEcCtD
Hydrocortisone—Sweating increased—Cisplatin—esophageal cancer	0.000311	0.0037	CcSEcCtD
Hydrocortisone—Skin discolouration—Methotrexate—esophageal cancer	0.000309	0.00367	CcSEcCtD
Hydrocortisone—Gastroenteritis—Capecitabine—esophageal cancer	0.000307	0.00365	CcSEcCtD
Hydrocortisone—CYP3A5—digestive system—esophageal cancer	0.000295	0.0166	CbGeAlD
Hydrocortisone—NR3C1—digestive system—esophageal cancer	0.000293	0.0164	CbGeAlD
Hydrocortisone—Increased appetite—Capecitabine—esophageal cancer	0.000289	0.00344	CcSEcCtD
Hydrocortisone—Inflammation—Methotrexate—esophageal cancer	0.000287	0.00342	CcSEcCtD
Hydrocortisone—Vasculitis—Methotrexate—esophageal cancer	0.000286	0.0034	CcSEcCtD
Hydrocortisone—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00028	0.00333	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000279	0.00332	CcSEcCtD
Hydrocortisone—Myocardial infarction—Cisplatin—esophageal cancer	0.000279	0.00332	CcSEcCtD
Hydrocortisone—Cardiac failure—Capecitabine—esophageal cancer	0.000279	0.00332	CcSEcCtD
Hydrocortisone—Lethargy—Capecitabine—esophageal cancer	0.000277	0.0033	CcSEcCtD
Hydrocortisone—Osteoarthritis—Capecitabine—esophageal cancer	0.000272	0.00324	CcSEcCtD
Hydrocortisone—Skin exfoliation—Methotrexate—esophageal cancer	0.000266	0.00317	CcSEcCtD
Hydrocortisone—ABCG2—lung—esophageal cancer	0.000265	0.0149	CbGeAlD
Hydrocortisone—Bradycardia—Cisplatin—esophageal cancer	0.00026	0.00309	CcSEcCtD
Hydrocortisone—Irritability—Capecitabine—esophageal cancer	0.00026	0.00309	CcSEcCtD
Hydrocortisone—Cardiac arrest—Capecitabine—esophageal cancer	0.000259	0.00308	CcSEcCtD
Hydrocortisone—Mood swings—Capecitabine—esophageal cancer	0.000258	0.00307	CcSEcCtD
Hydrocortisone—Ecchymosis—Methotrexate—esophageal cancer	0.000252	0.003	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Cisplatin—esophageal cancer	0.000251	0.00298	CcSEcCtD
Hydrocortisone—Dry skin—Capecitabine—esophageal cancer	0.000249	0.00297	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Capecitabine—esophageal cancer	0.000248	0.00296	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Methotrexate—esophageal cancer	0.000248	0.00295	CcSEcCtD
Hydrocortisone—Hypokalaemia—Capecitabine—esophageal cancer	0.000247	0.00294	CcSEcCtD
Hydrocortisone—CYP3A5—lung—esophageal cancer	0.000246	0.0138	CbGeAlD
Hydrocortisone—NR3C1—lung—esophageal cancer	0.000244	0.0137	CbGeAlD
Hydrocortisone—Muscular weakness—Capecitabine—esophageal cancer	0.00024	0.00285	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00024	0.00285	CcSEcCtD
Hydrocortisone—Eye disorder—Cisplatin—esophageal cancer	0.000238	0.00284	CcSEcCtD
Hydrocortisone—Abdominal distension—Capecitabine—esophageal cancer	0.000237	0.00282	CcSEcCtD
Hydrocortisone—Thrombophlebitis—Methotrexate—esophageal cancer	0.000234	0.00278	CcSEcCtD
Hydrocortisone—Diabetes mellitus—Methotrexate—esophageal cancer	0.000233	0.00277	CcSEcCtD
Hydrocortisone—Immune system disorder—Cisplatin—esophageal cancer	0.000231	0.00274	CcSEcCtD
Hydrocortisone—Sweating increased—Capecitabine—esophageal cancer	0.000229	0.00272	CcSEcCtD
Hydrocortisone—Arrhythmia—Cisplatin—esophageal cancer	0.000228	0.00271	CcSEcCtD
Hydrocortisone—Levonorgestrel—CYP19A1—esophageal cancer	0.000225	0.0624	CrCbGaD
Hydrocortisone—Malnutrition—Cisplatin—esophageal cancer	0.000222	0.00264	CcSEcCtD
Hydrocortisone—Erythema—Cisplatin—esophageal cancer	0.000222	0.00264	CcSEcCtD
Hydrocortisone—CYP3A4—digestive system—esophageal cancer	0.000221	0.0124	CbGeAlD
Hydrocortisone—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000218	0.0026	CcSEcCtD
Hydrocortisone—Weight increased—Capecitabine—esophageal cancer	0.000214	0.00255	CcSEcCtD
Hydrocortisone—Weight decreased—Capecitabine—esophageal cancer	0.000213	0.00253	CcSEcCtD
Hydrocortisone—Infestation—Capecitabine—esophageal cancer	0.00021	0.00249	CcSEcCtD
Hydrocortisone—Infestation NOS—Capecitabine—esophageal cancer	0.00021	0.00249	CcSEcCtD
Hydrocortisone—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000209	0.00249	CcSEcCtD
Hydrocortisone—Spironolactone—ABCC2—esophageal cancer	0.000209	0.0579	CrCbGaD
Hydrocortisone—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000207	0.00246	CcSEcCtD
Hydrocortisone—Lethargy—Methotrexate—esophageal cancer	0.000207	0.00246	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Cisplatin—esophageal cancer	0.000206	0.00245	CcSEcCtD
Hydrocortisone—ABCB1—epithelium—esophageal cancer	0.000206	0.0116	CbGeAlD
Hydrocortisone—Myocardial infarction—Capecitabine—esophageal cancer	0.000205	0.00244	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000205	0.00244	CcSEcCtD
Hydrocortisone—Danazol—CYP19A1—esophageal cancer	0.000205	0.0568	CrCbGaD
Hydrocortisone—Osteoarthritis—Methotrexate—esophageal cancer	0.000202	0.00241	CcSEcCtD
Hydrocortisone—Malaise—Cisplatin—esophageal cancer	0.0002	0.00238	CcSEcCtD
Hydrocortisone—Irritability—Methotrexate—esophageal cancer	0.000193	0.0023	CcSEcCtD
Hydrocortisone—Convulsion—Cisplatin—esophageal cancer	0.000192	0.00229	CcSEcCtD
Hydrocortisone—Mood swings—Methotrexate—esophageal cancer	0.000192	0.00228	CcSEcCtD
Hydrocortisone—Bradycardia—Capecitabine—esophageal cancer	0.000192	0.00228	CcSEcCtD
Hydrocortisone—Myalgia—Cisplatin—esophageal cancer	0.000189	0.00225	CcSEcCtD
Hydrocortisone—Haemoglobin—Capecitabine—esophageal cancer	0.000189	0.00225	CcSEcCtD
Hydrocortisone—Anxiety—Cisplatin—esophageal cancer	0.000188	0.00224	CcSEcCtD
Hydrocortisone—Haemorrhage—Capecitabine—esophageal cancer	0.000188	0.00224	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000188	0.00224	CcSEcCtD
Hydrocortisone—Discomfort—Cisplatin—esophageal cancer	0.000187	0.00222	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Capecitabine—esophageal cancer	0.000185	0.0022	CcSEcCtD
Hydrocortisone—ABCB1—trachea—esophageal cancer	0.000182	0.0102	CbGeAlD
Hydrocortisone—ABCG2—lymph node—esophageal cancer	0.000181	0.0102	CbGeAlD
Hydrocortisone—Oedema—Cisplatin—esophageal cancer	0.000181	0.00216	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Cisplatin—esophageal cancer	0.000181	0.00216	CcSEcCtD
Hydrocortisone—Infection—Cisplatin—esophageal cancer	0.00018	0.00214	CcSEcCtD
Hydrocortisone—Prednisolone—CYP2A6—esophageal cancer	0.000179	0.0497	CrCbGaD
Hydrocortisone—Nervous system disorder—Cisplatin—esophageal cancer	0.000178	0.00212	CcSEcCtD
Hydrocortisone—Tachycardia—Cisplatin—esophageal cancer	0.000177	0.00211	CcSEcCtD
Hydrocortisone—Skin disorder—Cisplatin—esophageal cancer	0.000176	0.0021	CcSEcCtD
Hydrocortisone—Eye disorder—Capecitabine—esophageal cancer	0.000176	0.00209	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Cisplatin—esophageal cancer	0.000175	0.00209	CcSEcCtD
Hydrocortisone—Methyltestosterone—CYP19A1—esophageal cancer	0.000173	0.048	CrCbGaD
Hydrocortisone—Anorexia—Cisplatin—esophageal cancer	0.000173	0.00206	CcSEcCtD
Hydrocortisone—Pancreatitis—Methotrexate—esophageal cancer	0.000172	0.00204	CcSEcCtD
Hydrocortisone—Immune system disorder—Capecitabine—esophageal cancer	0.00017	0.00202	CcSEcCtD
Hydrocortisone—Hypotension—Cisplatin—esophageal cancer	0.000169	0.00202	CcSEcCtD
Hydrocortisone—Arrhythmia—Capecitabine—esophageal cancer	0.000168	0.002	CcSEcCtD
Hydrocortisone—Betamethasone—CYP19A1—esophageal cancer	0.000167	0.0463	CrCbGaD
Hydrocortisone—NR3C1—lymph node—esophageal cancer	0.000167	0.00938	CbGeAlD
Hydrocortisone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000165	0.00197	CcSEcCtD
Hydrocortisone—Mental disorder—Capecitabine—esophageal cancer	0.000165	0.00196	CcSEcCtD
Hydrocortisone—Erythema—Capecitabine—esophageal cancer	0.000164	0.00195	CcSEcCtD
Hydrocortisone—Malnutrition—Capecitabine—esophageal cancer	0.000164	0.00195	CcSEcCtD
Hydrocortisone—Paraesthesia—Cisplatin—esophageal cancer	0.000163	0.00194	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000163	0.00193	CcSEcCtD
Hydrocortisone—Decreased appetite—Cisplatin—esophageal cancer	0.000158	0.00188	CcSEcCtD
Hydrocortisone—ABCB1—digestive system—esophageal cancer	0.000157	0.00879	CbGeAlD
Hydrocortisone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000157	0.00186	CcSEcCtD
Hydrocortisone—Infestation—Methotrexate—esophageal cancer	0.000156	0.00186	CcSEcCtD
Hydrocortisone—Infestation NOS—Methotrexate—esophageal cancer	0.000156	0.00186	CcSEcCtD
Hydrocortisone—Dexamethasone—NOS2—esophageal cancer	0.000156	0.0432	CrCbGaD
Hydrocortisone—Pain—Cisplatin—esophageal cancer	0.000155	0.00184	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Capecitabine—esophageal cancer	0.000152	0.00181	CcSEcCtD
Hydrocortisone—Feeling abnormal—Cisplatin—esophageal cancer	0.000149	0.00178	CcSEcCtD
Hydrocortisone—Malaise—Capecitabine—esophageal cancer	0.000148	0.00176	CcSEcCtD
Hydrocortisone—Vertigo—Capecitabine—esophageal cancer	0.000147	0.00175	CcSEcCtD
Hydrocortisone—Syncope—Capecitabine—esophageal cancer	0.000147	0.00175	CcSEcCtD
Hydrocortisone—Progesterone—CYP1B1—esophageal cancer	0.000145	0.0401	CrCbGaD
Hydrocortisone—Loss of consciousness—Capecitabine—esophageal cancer	0.000144	0.00171	CcSEcCtD
Hydrocortisone—Body temperature increased—Cisplatin—esophageal cancer	0.000143	0.00171	CcSEcCtD
Hydrocortisone—Hypertension—Capecitabine—esophageal cancer	0.000141	0.00168	CcSEcCtD
Hydrocortisone—Haemoglobin—Methotrexate—esophageal cancer	0.000141	0.00167	CcSEcCtD
Hydrocortisone—Haemorrhage—Methotrexate—esophageal cancer	0.00014	0.00167	CcSEcCtD
Hydrocortisone—Myalgia—Capecitabine—esophageal cancer	0.000139	0.00166	CcSEcCtD
Hydrocortisone—Anxiety—Capecitabine—esophageal cancer	0.000139	0.00165	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000138	0.00165	CcSEcCtD
Hydrocortisone—Discomfort—Capecitabine—esophageal cancer	0.000138	0.00164	CcSEcCtD
Hydrocortisone—Testosterone—CYP1B1—esophageal cancer	0.000137	0.038	CrCbGaD
Hydrocortisone—Oedema—Capecitabine—esophageal cancer	0.000134	0.00159	CcSEcCtD
Hydrocortisone—Hypersensitivity—Cisplatin—esophageal cancer	0.000134	0.00159	CcSEcCtD
Hydrocortisone—Infection—Capecitabine—esophageal cancer	0.000133	0.00158	CcSEcCtD
Hydrocortisone—Dexamethasone—CYP1B1—esophageal cancer	0.000132	0.0367	CrCbGaD
Hydrocortisone—Shock—Capecitabine—esophageal cancer	0.000131	0.00156	CcSEcCtD
Hydrocortisone—Nervous system disorder—Capecitabine—esophageal cancer	0.000131	0.00156	CcSEcCtD
Hydrocortisone—Eye disorder—Methotrexate—esophageal cancer	0.000131	0.00156	CcSEcCtD
Hydrocortisone—ABCB1—lung—esophageal cancer	0.000131	0.00734	CbGeAlD
Hydrocortisone—Tachycardia—Capecitabine—esophageal cancer	0.00013	0.00155	CcSEcCtD
Hydrocortisone—Asthenia—Cisplatin—esophageal cancer	0.00013	0.00155	CcSEcCtD
Hydrocortisone—Skin disorder—Capecitabine—esophageal cancer	0.00013	0.00154	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Capecitabine—esophageal cancer	0.000129	0.00154	CcSEcCtD
Hydrocortisone—Anorexia—Capecitabine—esophageal cancer	0.000127	0.00152	CcSEcCtD
Hydrocortisone—Drospirenone—PTGS2—esophageal cancer	0.000127	0.0352	CrCbGaD
Hydrocortisone—Immune system disorder—Methotrexate—esophageal cancer	0.000126	0.00151	CcSEcCtD
Hydrocortisone—Hypotension—Capecitabine—esophageal cancer	0.000125	0.00149	CcSEcCtD
Hydrocortisone—Diarrhoea—Cisplatin—esophageal cancer	0.000124	0.00148	CcSEcCtD
Hydrocortisone—Megestrol acetate—ABCB1—esophageal cancer	0.000124	0.0342	CrCbGaD
Hydrocortisone—Mental disorder—Methotrexate—esophageal cancer	0.000123	0.00146	CcSEcCtD
Hydrocortisone—Malnutrition—Methotrexate—esophageal cancer	0.000122	0.00145	CcSEcCtD
Hydrocortisone—Erythema—Methotrexate—esophageal cancer	0.000122	0.00145	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000122	0.00145	CcSEcCtD
Hydrocortisone—Insomnia—Capecitabine—esophageal cancer	0.000121	0.00144	CcSEcCtD
Hydrocortisone—Paraesthesia—Capecitabine—esophageal cancer	0.00012	0.00143	CcSEcCtD
Hydrocortisone—Dyspepsia—Capecitabine—esophageal cancer	0.000118	0.0014	CcSEcCtD
Hydrocortisone—Decreased appetite—Capecitabine—esophageal cancer	0.000116	0.00138	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000115	0.00137	CcSEcCtD
Hydrocortisone—Vomiting—Cisplatin—esophageal cancer	0.000115	0.00137	CcSEcCtD
Hydrocortisone—Fatigue—Capecitabine—esophageal cancer	0.000115	0.00137	CcSEcCtD
Hydrocortisone—Rash—Cisplatin—esophageal cancer	0.000114	0.00136	CcSEcCtD
Hydrocortisone—Pain—Capecitabine—esophageal cancer	0.000114	0.00136	CcSEcCtD
Hydrocortisone—Dermatitis—Cisplatin—esophageal cancer	0.000114	0.00136	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Methotrexate—esophageal cancer	0.000113	0.00135	CcSEcCtD
Hydrocortisone—Progesterone—CYP2A6—esophageal cancer	0.000112	0.0309	CrCbGaD
Hydrocortisone—Feeling abnormal—Capecitabine—esophageal cancer	0.00011	0.00131	CcSEcCtD
Hydrocortisone—Malaise—Methotrexate—esophageal cancer	0.00011	0.00131	CcSEcCtD
Hydrocortisone—Vertigo—Methotrexate—esophageal cancer	0.00011	0.0013	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000109	0.0013	CcSEcCtD
Hydrocortisone—Nausea—Cisplatin—esophageal cancer	0.000108	0.00128	CcSEcCtD
Hydrocortisone—Urticaria—Capecitabine—esophageal cancer	0.000106	0.00126	CcSEcCtD
Hydrocortisone—Abdominal pain—Capecitabine—esophageal cancer	0.000106	0.00126	CcSEcCtD
Hydrocortisone—Body temperature increased—Capecitabine—esophageal cancer	0.000106	0.00126	CcSEcCtD
Hydrocortisone—Convulsion—Methotrexate—esophageal cancer	0.000106	0.00126	CcSEcCtD
Hydrocortisone—Myalgia—Methotrexate—esophageal cancer	0.000104	0.00123	CcSEcCtD
Hydrocortisone—Dexamethasone—ABCC2—esophageal cancer	0.000103	0.0286	CrCbGaD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000103	0.00123	CcSEcCtD
Hydrocortisone—Discomfort—Methotrexate—esophageal cancer	0.000103	0.00122	CcSEcCtD
Hydrocortisone—Dexamethasone—CYP2A6—esophageal cancer	0.000102	0.0283	CrCbGaD
Hydrocortisone—Testosterone—CYP19A1—esophageal cancer	0.0001	0.0279	CrCbGaD
Hydrocortisone—Anaphylactic shock—Methotrexate—esophageal cancer	9.95e-05	0.00118	CcSEcCtD
Hydrocortisone—Infection—Methotrexate—esophageal cancer	9.88e-05	0.00118	CcSEcCtD
Hydrocortisone—Hypersensitivity—Capecitabine—esophageal cancer	9.85e-05	0.00117	CcSEcCtD
Hydrocortisone—Nervous system disorder—Methotrexate—esophageal cancer	9.76e-05	0.00116	CcSEcCtD
Hydrocortisone—Dexamethasone—CYP19A1—esophageal cancer	9.72e-05	0.027	CrCbGaD
Hydrocortisone—Skin disorder—Methotrexate—esophageal cancer	9.66e-05	0.00115	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Methotrexate—esophageal cancer	9.62e-05	0.00114	CcSEcCtD
Hydrocortisone—Asthenia—Capecitabine—esophageal cancer	9.59e-05	0.00114	CcSEcCtD
Hydrocortisone—Anorexia—Methotrexate—esophageal cancer	9.48e-05	0.00113	CcSEcCtD
Hydrocortisone—Methylprednisolone—ABCB1—esophageal cancer	9.46e-05	0.0262	CrCbGaD
Hydrocortisone—Pruritus—Capecitabine—esophageal cancer	9.46e-05	0.00113	CcSEcCtD
Hydrocortisone—Triamcinolone—PTGS2—esophageal cancer	9.38e-05	0.026	CrCbGaD
Hydrocortisone—Hypotension—Methotrexate—esophageal cancer	9.3e-05	0.00111	CcSEcCtD
Hydrocortisone—Diarrhoea—Capecitabine—esophageal cancer	9.14e-05	0.00109	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	9.06e-05	0.00108	CcSEcCtD
Hydrocortisone—Insomnia—Methotrexate—esophageal cancer	9e-05	0.00107	CcSEcCtD
Hydrocortisone—ABCB1—lymph node—esophageal cancer	8.95e-05	0.00502	CbGeAlD
Hydrocortisone—Paraesthesia—Methotrexate—esophageal cancer	8.93e-05	0.00106	CcSEcCtD
Hydrocortisone—Dizziness—Capecitabine—esophageal cancer	8.84e-05	0.00105	CcSEcCtD
Hydrocortisone—Dyspepsia—Methotrexate—esophageal cancer	8.76e-05	0.00104	CcSEcCtD
Hydrocortisone—Decreased appetite—Methotrexate—esophageal cancer	8.65e-05	0.00103	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Methotrexate—esophageal cancer	8.59e-05	0.00102	CcSEcCtD
Hydrocortisone—Fatigue—Methotrexate—esophageal cancer	8.58e-05	0.00102	CcSEcCtD
Hydrocortisone—Pain—Methotrexate—esophageal cancer	8.51e-05	0.00101	CcSEcCtD
Hydrocortisone—Vomiting—Capecitabine—esophageal cancer	8.5e-05	0.00101	CcSEcCtD
Hydrocortisone—Rash—Capecitabine—esophageal cancer	8.43e-05	0.001	CcSEcCtD
Hydrocortisone—Dermatitis—Capecitabine—esophageal cancer	8.42e-05	0.001	CcSEcCtD
Hydrocortisone—Headache—Capecitabine—esophageal cancer	8.37e-05	0.000996	CcSEcCtD
Hydrocortisone—Feeling abnormal—Methotrexate—esophageal cancer	8.2e-05	0.000976	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Methotrexate—esophageal cancer	8.14e-05	0.000968	CcSEcCtD
Hydrocortisone—Nausea—Capecitabine—esophageal cancer	7.94e-05	0.000945	CcSEcCtD
Hydrocortisone—Urticaria—Methotrexate—esophageal cancer	7.9e-05	0.000941	CcSEcCtD
Hydrocortisone—Abdominal pain—Methotrexate—esophageal cancer	7.86e-05	0.000936	CcSEcCtD
Hydrocortisone—Body temperature increased—Methotrexate—esophageal cancer	7.86e-05	0.000936	CcSEcCtD
Hydrocortisone—Betamethasone—PTGS2—esophageal cancer	7.69e-05	0.0213	CrCbGaD
Hydrocortisone—Spironolactone—ABCB1—esophageal cancer	7.68e-05	0.0213	CrCbGaD
Hydrocortisone—Hypersensitivity—Methotrexate—esophageal cancer	7.33e-05	0.000872	CcSEcCtD
Hydrocortisone—Prednisone—ABCB1—esophageal cancer	7.24e-05	0.0201	CrCbGaD
Hydrocortisone—Asthenia—Methotrexate—esophageal cancer	7.14e-05	0.000849	CcSEcCtD
Hydrocortisone—Norethindrone—ABCB1—esophageal cancer	7.13e-05	0.0198	CrCbGaD
Hydrocortisone—Pruritus—Methotrexate—esophageal cancer	7.04e-05	0.000838	CcSEcCtD
Hydrocortisone—Diarrhoea—Methotrexate—esophageal cancer	6.81e-05	0.00081	CcSEcCtD
Hydrocortisone—Prednisolone—ABCB1—esophageal cancer	6.67e-05	0.0185	CrCbGaD
Hydrocortisone—Dizziness—Methotrexate—esophageal cancer	6.58e-05	0.000783	CcSEcCtD
Hydrocortisone—Betamethasone—ABCB1—esophageal cancer	6.53e-05	0.0181	CrCbGaD
Hydrocortisone—Vomiting—Methotrexate—esophageal cancer	6.33e-05	0.000753	CcSEcCtD
Hydrocortisone—Rash—Methotrexate—esophageal cancer	6.27e-05	0.000746	CcSEcCtD
Hydrocortisone—Dermatitis—Methotrexate—esophageal cancer	6.27e-05	0.000746	CcSEcCtD
Hydrocortisone—Headache—Methotrexate—esophageal cancer	6.23e-05	0.000742	CcSEcCtD
Hydrocortisone—Nausea—Methotrexate—esophageal cancer	5.91e-05	0.000703	CcSEcCtD
Hydrocortisone—Dexamethasone—PTGS2—esophageal cancer	4.47e-05	0.0124	CrCbGaD
Hydrocortisone—Progesterone—ABCB1—esophageal cancer	4.16e-05	0.0115	CrCbGaD
Hydrocortisone—Testosterone—ABCB1—esophageal cancer	3.93e-05	0.0109	CrCbGaD
Hydrocortisone—Dexamethasone—ABCB1—esophageal cancer	3.8e-05	0.0105	CrCbGaD
Hydrocortisone—CYP11B1—Metabolism—ABCB1—esophageal cancer	1.89e-05	0.000215	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CA2—esophageal cancer	1.87e-05	0.000214	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.86e-05	0.000213	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—NOTCH1—esophageal cancer	1.86e-05	0.000212	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	1.85e-05	0.000211	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—TPI1—esophageal cancer	1.84e-05	0.00021	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GSTO1—esophageal cancer	1.84e-05	0.00021	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—NOTCH1—esophageal cancer	1.84e-05	0.00021	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	1.83e-05	0.000209	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—TPI1—esophageal cancer	1.82e-05	0.000208	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GSTO1—esophageal cancer	1.82e-05	0.000208	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	1.82e-05	0.000208	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—BLVRB—esophageal cancer	1.82e-05	0.000207	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—SLC52A3—esophageal cancer	1.82e-05	0.000207	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—GSTT1—esophageal cancer	1.8e-05	0.000206	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CYP2A6—esophageal cancer	1.78e-05	0.000203	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.77e-05	0.000203	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CA1—esophageal cancer	1.77e-05	0.000202	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—SLC10A2—esophageal cancer	1.77e-05	0.000202	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ALDOB—esophageal cancer	1.76e-05	0.000201	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ALDOB—esophageal cancer	1.75e-05	0.0002	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ADH7—esophageal cancer	1.74e-05	0.000199	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PLCE1—esophageal cancer	1.74e-05	0.000199	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—PSME2—esophageal cancer	1.71e-05	0.000195	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—PSME1—esophageal cancer	1.71e-05	0.000195	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GAPDH—esophageal cancer	1.7e-05	0.000194	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ENO1—esophageal cancer	1.69e-05	0.000193	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PTGS1—esophageal cancer	1.69e-05	0.000193	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.69e-05	0.000193	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GAPDH—esophageal cancer	1.68e-05	0.000192	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CRABP1—esophageal cancer	1.68e-05	0.000192	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—CREBBP—esophageal cancer	1.68e-05	0.000192	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CRABP1—esophageal cancer	1.67e-05	0.00019	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CREBBP—esophageal cancer	1.67e-05	0.00019	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PSME1—esophageal cancer	1.66e-05	0.00019	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PSME2—esophageal cancer	1.66e-05	0.00019	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.65e-05	0.000189	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—EGFR—esophageal cancer	1.64e-05	0.000187	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CA2—esophageal cancer	1.62e-05	0.000185	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—NOTCH3—esophageal cancer	1.61e-05	0.000184	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GNG7—esophageal cancer	1.6e-05	0.000183	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GNG7—esophageal cancer	1.59e-05	0.000181	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.58e-05	0.000181	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	1.57e-05	0.000179	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.56e-05	0.000179	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CA1—esophageal cancer	1.54e-05	0.000176	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—SLC10A2—esophageal cancer	1.54e-05	0.000176	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ADH1B—esophageal cancer	1.53e-05	0.000174	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	1.52e-05	0.000174	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PLCE1—esophageal cancer	1.51e-05	0.000172	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ADH7—esophageal cancer	1.51e-05	0.000172	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ALDH2—esophageal cancer	1.5e-05	0.000171	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—NOS3—esophageal cancer	1.49e-05	0.00017	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	1.49e-05	0.00017	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.49e-05	0.00017	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ALDH2—esophageal cancer	1.49e-05	0.00017	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—CREBBP—esophageal cancer	1.46e-05	0.000167	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—TYMP—esophageal cancer	1.46e-05	0.000166	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.45e-05	0.000166	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—NOTCH2—esophageal cancer	1.44e-05	0.000165	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CYP1B1—esophageal cancer	1.44e-05	0.000164	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GSTT1—esophageal cancer	1.43e-05	0.000163	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.43e-05	0.000163	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—PIK3CA—esophageal cancer	1.42e-05	0.000162	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CYP26A1—esophageal cancer	1.42e-05	0.000162	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GSTT1—esophageal cancer	1.41e-05	0.000161	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CA2—esophageal cancer	1.41e-05	0.000161	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CYP2A6—esophageal cancer	1.41e-05	0.000161	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CYP2A6—esophageal cancer	1.4e-05	0.00016	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—ERBB2—esophageal cancer	1.4e-05	0.000159	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ALOX15—esophageal cancer	1.38e-05	0.000158	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CYP19A1—esophageal cancer	1.35e-05	0.000154	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	1.35e-05	0.000154	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ENO1—esophageal cancer	1.34e-05	0.000153	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PTGS1—esophageal cancer	1.34e-05	0.000153	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.34e-05	0.000153	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PTGS1—esophageal cancer	1.33e-05	0.000151	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ENO1—esophageal cancer	1.33e-05	0.000151	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ADH1B—esophageal cancer	1.32e-05	0.000151	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—TPI1—esophageal cancer	1.32e-05	0.000151	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GSTO1—esophageal cancer	1.32e-05	0.000151	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PSME1—esophageal cancer	1.32e-05	0.00015	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PSME2—esophageal cancer	1.32e-05	0.00015	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ADH7—esophageal cancer	1.31e-05	0.00015	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PLCE1—esophageal cancer	1.31e-05	0.00015	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—NOS3—esophageal cancer	1.31e-05	0.00015	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PSME1—esophageal cancer	1.31e-05	0.000149	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PSME2—esophageal cancer	1.31e-05	0.000149	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.3e-05	0.000149	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ALDOB—esophageal cancer	1.26e-05	0.000144	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—TYMP—esophageal cancer	1.26e-05	0.000144	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—CREBBP—esophageal cancer	1.26e-05	0.000144	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.24e-05	0.000141	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCND1—esophageal cancer	1.23e-05	0.000141	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—HMOX1—esophageal cancer	1.23e-05	0.000141	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CYP26A1—esophageal cancer	1.23e-05	0.00014	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GAPDH—esophageal cancer	1.22e-05	0.000139	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—SMAD4—esophageal cancer	1.21e-05	0.000138	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.21e-05	0.000138	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CRABP1—esophageal cancer	1.21e-05	0.000138	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PTGS2—esophageal cancer	1.2e-05	0.000137	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ALOX15—esophageal cancer	1.2e-05	0.000137	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CDKN1A—esophageal cancer	1.19e-05	0.000136	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ABCB1—esophageal cancer	1.18e-05	0.000135	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ADH1B—esophageal cancer	1.15e-05	0.000131	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GNG7—esophageal cancer	1.15e-05	0.000131	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GSTO1—esophageal cancer	1.14e-05	0.00013	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—TPI1—esophageal cancer	1.14e-05	0.00013	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CYP1B1—esophageal cancer	1.14e-05	0.00013	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—EP300—esophageal cancer	1.13e-05	0.00013	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—NOS3—esophageal cancer	1.13e-05	0.000129	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CYP1B1—esophageal cancer	1.13e-05	0.000129	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.13e-05	0.000129	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.12e-05	0.000128	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.12e-05	0.000128	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—TYMP—esophageal cancer	1.1e-05	0.000126	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.09e-05	0.000125	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.08e-05	0.000123	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ALDH2—esophageal cancer	1.07e-05	0.000123	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.07e-05	0.000122	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CYP19A1—esophageal cancer	1.07e-05	0.000122	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CYP19A1—esophageal cancer	1.06e-05	0.000121	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.06e-05	0.000121	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.05e-05	0.00012	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.04e-05	0.000119	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ALOX15—esophageal cancer	1.04e-05	0.000119	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PTGS2—esophageal cancer	1.03e-05	0.000118	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GSTT1—esophageal cancer	1.02e-05	0.000117	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CYP2A6—esophageal cancer	1.01e-05	0.000115	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—MYC—esophageal cancer	9.98e-06	0.000114	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—EP300—esophageal cancer	9.96e-06	0.000114	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GSTO1—esophageal cancer	9.95e-06	0.000114	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—TPI1—esophageal cancer	9.95e-06	0.000114	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GNG7—esophageal cancer	9.93e-06	0.000113	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MYC—esophageal cancer	9.89e-06	0.000113	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—HMOX1—esophageal cancer	9.75e-06	0.000111	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—EGFR—esophageal cancer	9.67e-06	0.00011	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—HMOX1—esophageal cancer	9.67e-06	0.00011	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PTGS1—esophageal cancer	9.58e-06	0.000109	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ENO1—esophageal cancer	9.58e-06	0.000109	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ALDOB—esophageal cancer	9.54e-06	0.000109	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	9.51e-06	0.000109	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CA1—esophageal cancer	9.51e-06	0.000109	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PSME1—esophageal cancer	9.44e-06	0.000108	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PSME2—esophageal cancer	9.44e-06	0.000108	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ABCB1—esophageal cancer	9.36e-06	0.000107	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ALDH2—esophageal cancer	9.31e-06	0.000106	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ABCB1—esophageal cancer	9.28e-06	0.000106	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GAPDH—esophageal cancer	9.18e-06	0.000105	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	9.16e-06	0.000105	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CRABP1—esophageal cancer	9.1e-06	0.000104	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.94e-06	0.000102	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—NOTCH1—esophageal cancer	8.93e-06	0.000102	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	8.87e-06	0.000101	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GSTT1—esophageal cancer	8.85e-06	0.000101	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CYP2A6—esophageal cancer	8.75e-06	9.99e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.72e-06	9.96e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CA2—esophageal cancer	8.7e-06	9.93e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GNG7—esophageal cancer	8.65e-06	9.88e-05	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—EP300—esophageal cancer	8.58e-06	9.8e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PIK3CA—esophageal cancer	8.39e-06	9.58e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ENO1—esophageal cancer	8.3e-06	9.48e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PTGS1—esophageal cancer	8.3e-06	9.48e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PSME2—esophageal cancer	8.18e-06	9.34e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PSME1—esophageal cancer	8.18e-06	9.34e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CYP1B1—esophageal cancer	8.15e-06	9.3e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TP53—esophageal cancer	8.12e-06	9.27e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ALDH2—esophageal cancer	8.11e-06	9.26e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—CREBBP—esophageal cancer	8.1e-06	9.25e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PLCE1—esophageal cancer	8.09e-06	9.24e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ADH7—esophageal cancer	8.09e-06	9.24e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CREBBP—esophageal cancer	7.9e-06	9.02e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GSTT1—esophageal cancer	7.71e-06	8.81e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CYP19A1—esophageal cancer	7.66e-06	8.75e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CYP2A6—esophageal cancer	7.63e-06	8.71e-05	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PIK3CA—esophageal cancer	7.37e-06	8.41e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ENO1—esophageal cancer	7.23e-06	8.25e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PTGS1—esophageal cancer	7.23e-06	8.25e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.22e-06	8.25e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.14e-06	8.15e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PSME1—esophageal cancer	7.12e-06	8.13e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PSME2—esophageal cancer	7.12e-06	8.13e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.09e-06	8.1e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—NOS3—esophageal cancer	7.07e-06	8.08e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CYP1B1—esophageal cancer	7.05e-06	8.06e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—HMOX1—esophageal cancer	6.99e-06	7.98e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—TYMP—esophageal cancer	6.78e-06	7.74e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ABCB1—esophageal cancer	6.71e-06	7.66e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CYP19A1—esophageal cancer	6.63e-06	7.57e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.59e-06	7.53e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PTGS2—esophageal cancer	6.47e-06	7.39e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.43e-06	7.34e-05	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PIK3CA—esophageal cancer	6.35e-06	7.25e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CREBBP—esophageal cancer	6.26e-06	7.14e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CREBBP—esophageal cancer	6.2e-06	7.08e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CYP1B1—esophageal cancer	6.15e-06	7.02e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—TPI1—esophageal cancer	6.13e-06	7e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.13e-06	7e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—HMOX1—esophageal cancer	6.05e-06	6.91e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.94e-06	6.78e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.88e-06	6.71e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ABCB1—esophageal cancer	5.81e-06	6.63e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CYP19A1—esophageal cancer	5.78e-06	6.6e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.66e-06	6.46e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.61e-06	6.4e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—NOS3—esophageal cancer	5.6e-06	6.4e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—NOS3—esophageal cancer	5.55e-06	6.34e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—EP300—esophageal cancer	5.38e-06	6.15e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GNG7—esophageal cancer	5.33e-06	6.09e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—HMOX1—esophageal cancer	5.27e-06	6.02e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PTGS2—esophageal cancer	5.12e-06	5.85e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PTGS2—esophageal cancer	5.08e-06	5.8e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ALDH2—esophageal cancer	5e-06	5.71e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—MYC—esophageal cancer	4.81e-06	5.49e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.75e-06	5.43e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.7e-06	5.36e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CREBBP—esophageal cancer	4.48e-06	5.12e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.45e-06	5.09e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ENO1—esophageal cancer	4.45e-06	5.09e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.39e-06	5.02e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PSME1—esophageal cancer	4.39e-06	5.01e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PSME2—esophageal cancer	4.39e-06	5.01e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—EP300—esophageal cancer	4.26e-06	4.87e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—EP300—esophageal cancer	4.22e-06	4.82e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—NOS3—esophageal cancer	4.01e-06	4.58e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	3.98e-06	4.55e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CREBBP—esophageal cancer	3.88e-06	4.43e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.79e-06	4.32e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PTGS2—esophageal cancer	3.67e-06	4.19e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.56e-06	4.07e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—NOS3—esophageal cancer	3.48e-06	3.97e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CREBBP—esophageal cancer	3.38e-06	3.86e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.25e-06	3.71e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PTGS2—esophageal cancer	3.18e-06	3.63e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PIK3CA—esophageal cancer	3.15e-06	3.6e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PIK3CA—esophageal cancer	3.12e-06	3.57e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.12e-06	3.56e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—EP300—esophageal cancer	3.05e-06	3.49e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—NOS3—esophageal cancer	3.03e-06	3.46e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PTGS2—esophageal cancer	2.77e-06	3.16e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—EP300—esophageal cancer	2.64e-06	3.02e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—EP300—esophageal cancer	2.3e-06	2.63e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PIK3CA—esophageal cancer	2.26e-06	2.58e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.08e-06	2.38e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PIK3CA—esophageal cancer	1.96e-06	2.23e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—NOS3—esophageal cancer	1.87e-06	2.13e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.71e-06	1.95e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PIK3CA—esophageal cancer	1.7e-06	1.95e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—EP300—esophageal cancer	1.42e-06	1.62e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.05e-06	1.2e-05	CbGpPWpGaD
